Gerhard Zugmaier

Philipps University of Marburg — Germany

Medicine · Health Sciences

55h-index15.0kcitations224works13.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(105), CAR-T cell therapy research(103), Lymphoma Diagnosis and Treatment(37), Chronic Myeloid Leukemia Treatments(37), Chronic Lymphocytic Leukemia Research(34)

Publications224 total

Blinatumomab consolidation in children with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a randomized multicenter phase 3 study
Leukemia·2025Open Access
Blinatumomab mitigates the impact of traditional adverse prognosticators among children with standard risk b-acute lymphoblastic leukemia: Updated results of the Children's oncology group (COG) Trial AALL1731
Blood·2025Open Access
Boolean Algebra (Mathematical Logic) for Differential Diagnosis of Neurologic Disorders
Journal of Clinical Research and Reports·2025Open Access
Boolean Algebra (Mathematical Logic) for Diagnosis of Hematologic Disorders
Journal of Clinical Research and Reports·2025Open Access
Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial
The Lancet Haematology·2025· 9 citedOpen Access
Immunotherapy with blinatumomab in B-cell acute lymphoblastic leukemia: a narrative review of efficacy, toxicity, and patient management in relapse and consolidation
Annals of Blood·2025· 2 citedOpen Access
Pooled biomarker analysis of the association of baseline T regulatory cells with response and T-cell recovery profiles with blinatumomab treatment
The Oncologist·2025Open Access
POS1113 TREATMENT OF SEVERE SYSTEMIC SCLEROSIS WITH BLINATUMOMAB, A BISPECIFIC ANTI-CD3/CD19 T CELL ENGAGER
Annals of the Rheumatic Diseases·2025· 2 citedOpen Access
Truncated form of human CD19 antigen as a suicide gene to control T-cell alloreactivity: ΔCD19
Haematologica·2025Open Access
Mathematical logic (Boolean Algebra) for computation of Treatment Recommendation in Systemic Sclerosis
Journal of Clinical Research and Reports·2025· 1 citedOpen Access
B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis
Sclerosis·2025· 4 citedOpen Access
Boolean Algebra (Mathematical Logic) for Computational Differential Diagnosis in Medicine
Journal of Clinical Research and Reports·2025· 1 citedOpen Access
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children
New England Journal of Medicine·2024· 133 citedOpen Access
Single-Agent Subcutaneous Blinatumomab for Advanced B-Cell Acute Lymphoblastic Leukemia: Long-Term Follow-up from a Phase 1b Dose Expansion Cohort
Blood·2024· 3 citedOpen Access
Outcomes of Children and Young Adults with B-Cell Acute Lymphoblastic Leukemia Given Blinatumomab As Last Consolidation Treatment before Allogeneic Hematopoietic Cell Transplantation
Blood·2024
Blinatumomab Added to Chemotherapy Improves Disease-Free Survival in Newly Diagnosed NCI Standard Risk Pediatric B-Acute Lymphoblastic Leukemia: Results from the Randomized Children's Oncology Group Study AALL1731
Blood·2024· 6 citedOpen Access
Outcomes of children and young adults with B-cell acute lymphoblastic leukemia given blinatumomab as last consolidation treatment before allogeneic hematopoietic stem cell transplantation
Haematologica·2024· 5 citedOpen Access
Blinatumomab is associated with better post-transplant outcome than chemotherapy in children with high-risk first-relapse B-cell acute lymphoblastic leukemia irrespective of the conditioning regimen
Haematologica·2024· 2 citedOpen Access
Boolean Algebra for Laboratory Diagnostics in Medicine
Journal of Clinical Research and Reports·2024Open Access
Application of blinatumomab, a bispecific anti-CD3/CD19 T-cell engager, in treating severe systemic sclerosis: A case study
European Journal of Cancer·2024· 64 citedOpen Access
page 1 of 12Next →

Frequent Co-authors

Ralf C. Bargou(15), Nicola Gökbuget(14), Max S. Topp(12), Peter Kufer(12), Monika Brüggemann(11), Matthias Klinger(11), Andreas Viardot(9), Matthias Stelljes(9), Svenja Neumann(8), Hermann Einsele(8), Patrick A. Baeuerle(8), Lia Gore(8), Dirk Nagorsen(7), Arend von Stackelberg(6), Franco Locatelli(6), Rupert Handgretinger(6), Hagop M. Kantarjian(5), Margit Schmidt(5), Dieter Hoelzer(5), Noemi Mergen(5)